Zhang M, Xiang C, Niu R, He X, Luo W, Liu W
Neural Regen Res. 2024; 20(7):1883-1899.
PMID: 39254548
PMC: 11691476.
DOI: 10.4103/NRR.NRR-D-24-00048.
da Silva Beraldo I, Prates Rodrigues M, Polanczyk R, Verano-Braga T, Lopes-Aguiar C
Adv Exp Med Biol. 2024; 1443:129-158.
PMID: 38409419
DOI: 10.1007/978-3-031-50624-6_7.
Chu Y, Hirst W, Federoff H, Harms A, Stoessl A, Kordower J
Brain. 2023; 147(2):444-457.
PMID: 38006313
PMC: 10834249.
DOI: 10.1093/brain/awad388.
Keighron C, Avazzadeh S, Goljanek-Whysall K, McDonagh B, Howard L, Ritter T
Biomedicines. 2023; 11(3).
PMID: 36979707
PMC: 10045119.
DOI: 10.3390/biomedicines11030728.
Wang M, Kou J, Wang C, Yu X, Xie X, Pang X
Iran J Basic Med Sci. 2021; 23(12):1576-1583.
PMID: 33489032
PMC: 7811813.
DOI: 10.22038/ijbms.2020.47184.10858.
A possible relationship between telomere length and markers of neurodegeneration in rat brain after welding fume inhalation exposure.
Shoeb M, Mustafa G, Kodali V, Smith K, Roach K, Boyce G
Environ Res. 2019; 180:108900.
PMID: 31711660
PMC: 6899181.
DOI: 10.1016/j.envres.2019.108900.
Role of the chanzyme TRPM7 in the nervous system in health and disease.
Abumaria N, Li W, Clarkson A
Cell Mol Life Sci. 2019; 76(17):3301-3310.
PMID: 31073743
PMC: 11105578.
DOI: 10.1007/s00018-019-03124-2.
Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
Ittner L, Klugmann M, Ke Y
Br J Pharmacol. 2019; 176(18):3649-3665.
PMID: 30817847
PMC: 6715621.
DOI: 10.1111/bph.14637.
Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
Boyko A, Troyanova N, Kovalenko E, Sapozhnikov A
Int J Mol Sci. 2017; 18(12).
PMID: 29211044
PMC: 5751236.
DOI: 10.3390/ijms18122633.
Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.
Fernandez M, Kim J, Budde J, Black K, Medvedeva A, Saef B
PLoS Genet. 2017; 13(11):e1007045.
PMID: 29091718
PMC: 5683650.
DOI: 10.1371/journal.pgen.1007045.
Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease.
SIlIndIr GUnay M, Ozer A, Chalon S
Curr Neuropharmacol. 2015; 14(4):376-91.
PMID: 26714584
PMC: 4876593.
DOI: 10.2174/1570159x14666151230124904.
Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
Janowska M, Wu K, Baum J
Sci Rep. 2015; 5:15164.
PMID: 26477939
PMC: 4609965.
DOI: 10.1038/srep15164.
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.
Barreto G, Iarkov A, Echeverria Moran V
Front Aging Neurosci. 2015; 6:340.
PMID: 25620929
PMC: 4288130.
DOI: 10.3389/fnagi.2014.00340.
Neurodegeneration across stages of cognitive decline in Parkinson disease.
Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf A, Duda J
Arch Neurol. 2011; 68(12):1562-8.
PMID: 22159053
PMC: 3290902.
DOI: 10.1001/archneurol.2011.725.
Primary support cultures of hippocampal and substantia nigra neurons.
Fath T, Ke Y, Gunning P, Gotz J, Ittner L
Nat Protoc. 2009; 4(1):78-85.
PMID: 19131959
DOI: 10.1038/nprot.2008.199.
Neuroproteomics as a promising tool in Parkinson's disease research.
Pienaar I, Daniels W, Gotz J
J Neural Transm (Vienna). 2008; 115(10):1413-30.
PMID: 18523721
PMC: 2862282.
DOI: 10.1007/s00702-008-0070-3.
A decade of tau transgenic animal models and beyond.
Gotz J, Deters N, Doldissen A, Bokhari L, Ke Y, Wiesner A
Brain Pathol. 2007; 17(1):91-103.
PMID: 17493043
PMC: 8095624.
DOI: 10.1111/j.1750-3639.2007.00051.x.
Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?.
Mollenhauer B, Bibl M, Esselmann H, Steinacker P, Trenkwalder C, Wiltfang J
J Neural Transm (Vienna). 2007; 114(7):919-27.
PMID: 17318305
DOI: 10.1007/s00702-007-0629-4.
Redox proteomics in some age-related neurodegenerative disorders or models thereof.
Butterfield D, Abdul H, Newman S, Reed T
NeuroRx. 2006; 3(3):344-57.
PMID: 16815218
PMC: 3593385.
DOI: 10.1016/j.nurx.2006.05.003.
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.
Tsuang D, Wilson R, Lopez O, Luedecking-Zimmer E, Leverenz J, DeKosky S
Neurology. 2005; 64(3):509-13.
PMID: 15699383
PMC: 1487185.
DOI: 10.1212/01.WNL.0000150892.81839.D1.